Indgene IPO: Here's what a host of brokerages say about the issue

Produced by: Pawan Kumar Nahar

Indegene IPO details

IPO Dates: May 6-8 Price Band: 430-452 Lot size: 33 shares Issue size: 1,841 crore

Positive brokerages

Brokerage firms including StoxBox, Hensex Securities, Indsec Securities, SBICap Securities, Mehta Equities, SMIFS, Reliance Securities, Swastika Investmart, Anand Rathi Research and Ventura Securities have suggested to subscribe to the issue.

Other views

Other brokerages including Ashika Stock Broking ad Sushil Finance have decided not to rate the issue. However, their view is positive on the issue but have some concerns on the valuations of the IPO.

Latest GMP

Indegene is currently commanding a grey market premium of Rs 255-260 apiece, suggesting a listing pop of 55-56 per cent for the investors against the upper end of the price band.

Managers and Regsistrars

Kotak Mahindra Capital, Citigroup Global Markets India, JP Morgan India and Nomura Financial Advisory and Securities (India) are the book running lead managers of the Indegene IPO, while Link Intime India is the registrar for the issue.

Other details

Indegene is likely to finalize the basis of allotment of its shares on Thursday, May 9. The company will make its Dalal Street debut on Monday, May 13 on both BSE and NSE. 50% shares are reserved for the qualified institutional bidders (QIBs), 15% per for non-institutional investors (NIIs) and 35% for the retail investors.

Disclaimer

Business Today provides stock market news for informational purposes only and that should not be construed as investment advice. Readers are encouraged to consult a qualified financial advisor before making any investment decisions.